Trinity Biotech Financial Market Data
| Last Close 18-Aug-2008 |
$3.15 |
Price/ Sales Ratio |
0.44 |
| 52-Week High |
$11.64 |
Price/ Book Ratio |
0.46 |
| 52-Week Low |
$3.05 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
2.0 |
Price/ Cash Flow Ratio |
4.10 |
| Market Cap (mil.) |
-- |
Return on Assets |
(15.2%) |
| Shares Outstanding (mil.) |
-- |
Return on Equity |
(23.3%) |
| Dividend Rate |
-- |
Current Ratio |
1.83 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
0.31 |
| # of Institutional Holders |
39 |
% Owned by Institutions |
47.0% |
| Latest Short Interest Ratio |
3.33 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
21.4% |
80.2% |
177.1% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
